# Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

> **NCT01015196** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 832 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Zavedos
- **DRUG:** Cerubidine

## Key facts

- **NCT ID:** NCT01015196
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 832 (ACTUAL)
- **Last updated:** 2009-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015196, "Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01015196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
